GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » Debt-to-Revenue

Hanmi Science Co (XKRX:008930) Debt-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Hanmi Science Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Hanmi Science Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Hanmi Science Co's annualized Revenue for the quarter that ended in Mar. 2024 was ₩1,280,609 Mil. Hanmi Science Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.00.


Hanmi Science Co Debt-to-Revenue Historical Data

The historical data trend for Hanmi Science Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co Debt-to-Revenue Chart

Hanmi Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.06 0.06 0.19 0.17

Hanmi Science Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.15 0.16 0.16 -

Competitive Comparison of Hanmi Science Co's Debt-to-Revenue

For the Medical Distribution subindustry, Hanmi Science Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Science Co's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hanmi Science Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hanmi Science Co's Debt-to-Revenue falls into.



Hanmi Science Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Hanmi Science Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(202967.456 + 10768.617) / 1247906.379
=0.17

Hanmi Science Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 1280609.328
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Hanmi Science Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hanmi Science Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Science Co (XKRX:008930) Business Description

Traded in Other Exchanges
N/A
Address
214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines